Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M116Revenue (TTM) $M9.5Net Margin (%)-737.9Altman Z-Score-9.6
Enterprise Value $M49.4EPS (TTM) $-1.4Operating Margin %-673.4Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.7Pre-tax Margin (%)-737.9Higher ROA y-yN
Price/Book2.010-y EBITDA Growth Rate %--Quick Ratio6.3Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %-17.1Current Ratio6.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-432.1ROA % (ttm)-53.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-80.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M50.7ROIC % (ttm)-1,430.0Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

INFI is held by these investors:



INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIOTECHNOLOGY VALUE FUND L P 2017-10-04Buy1,600,046$1.2680.95view
VENUTI MICHAEL CDirector 2017-03-17Sell6,250$3.48-34.48view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2017-01-03Buy4,379$1.3470.15view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-30Buy742,401$1.3470.15view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-20Buy654,921$1.3174.05view
KANGO SUJAYChief Commercial Officer 2016-12-13Sell75,000$1.2878.13view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-02Buy201,394$1.1991.6view
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-79.14view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-79.22view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-82.2view

Quarterly/Annual Reports about INFI:

News about INFI:

Articles On GuruFocus.com
Infinity Announces IPI-549 Late-Breaking Presentation at SITC Annual Meeting Oct 12 2017 
Infinity To Present At The 2017 BIO Investor Forum Oct 10 2017 
Infinity Pharmaceuticals and Bristol-Myers Squibb Expand Clinical Collaboration Evaluating IPI-549 i Sep 25 2017 
Infinity Provides Company Update and Reports Second Quarter 2017 Financial Results Aug 03 2017 
Infinity Amends PI3K-Delta,Gamma Agreement with Takeda Oncology Jul 27 2017 
Infinity Announces the Date of Its Second Quarter 2017 Financial Results Conference Call and Webcast Jul 21 2017 
Infinity to Participate in Three Upcoming Conferences Jun 14 2017 
Infinity Provides Company Update and Reports First Quarter 2017 Financial Results May 09 2017 
Infinity Announces the Date of Its First Quarter 2017 Financial Results Conference Call and Webcast Apr 26 2017 
Updated Phase 1 Data for IPI-549 Presented at AACR Annual Meeting 2017 Apr 01 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK